DOW JONES NEWSWIRES Hologic Inc. (HOLX) said an appellate court has ruled in its favor in relation to a suit it had filed in early 2008 against SenoRx Inc. alleging infringement on some Hologic brachytherapy patent claims. The maker of diagnostics, medical-imaging systems and surgical products geared toward women said the U.S. Court of Appeals for the Federal Circuit reversed decisions that had previously been reached in favor of SenoRx. The court's decision to overturn the previous judgment came as the court cited "an incorrect claim construction," Hologic said. SenoRx was bought by C.R. Bard Inc. (BCR) in July of 2008. A Bard spokesman wasn't immediately available for comment. "We are extremely pleased that the Court adopted our proffered claim construction and reinstated the validity of the claims of this pioneering patent in the area of breast brachytherapy," said Hologic general counsel Mark Casey. Shares of Hologic were recently up 3.7% to $20.57. The stock has risen 22% in the past year. -By Nathan Becker, Dow Jones Newswires; 212-416-2855; nathan.becker@dowjones.com;
